Physicochemical Properties
| Molecular Formula | C14H12N6O2S |
| Molecular Weight | 328.35 |
| Exact Mass | 328.074 |
| CAS # | 507487-89-0 |
| PubChem CID | 447961 |
| Appearance | Light yellow to yellow solid powder |
| LogP | 3.668 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 3 |
| Heavy Atom Count | 23 |
| Complexity | 423 |
| Defined Atom Stereocenter Count | 0 |
| InChi Key | DYTKVFHLKPDNRW-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C14H12N6O2S/c1-8-12(23-13(15)17-8)11-5-6-16-14(19-11)18-9-3-2-4-10(7-9)20(21)22/h2-7H,1H3,(H2,15,17)(H,16,18,19) |
| Chemical Name | 4-methyl-5-[2-(3-nitroanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: This product requires protection from light (avoid light exposure) during transportation and storage. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| Targets | CDK2 CDK9 |
| References |
[1]. Design, synthesis and biological evaluation of novel aminopyrazole- and 7-azaindole-based Nek1 inhibitors and their effects on zebrafish kidney development. Bioorg Med Chem Lett. 2021;53:128418. |
Solubility Data
| Solubility (In Vitro) | DMSO : 12.5 mg/mL (38.07 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (6.33 mM) (saturation unknown) in 10% DMSO + 40% PEG300 +5% Tween-80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 + to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.0455 mL | 15.2277 mL | 30.4553 mL | |
| 5 mM | 0.6091 mL | 3.0455 mL | 6.0911 mL | |
| 10 mM | 0.3046 mL | 1.5228 mL | 3.0455 mL |